Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial

BACKGROUND: Following radical nephro-ureterectomy for urothelial carcinoma of the upper urinary tract (UUT), the reported bladder recurrence rate of urothelial carcinoma is 22–47%. A single intravesical instillation of chemotherapy within 10 days following nephro-ureterectomy has the potential to de...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Contemp Clin Trials Commun
Autori principali: van Doeveren, T., van Leeuwen, P.J., Aben, K.K.H., van der Aa, M., Barendrecht, M., Boevé, E.R., Cornel, E.B., van der Heijden, A.G., Hendricksen, K., Hirdes, W., Kooistra, A., Kroon, B., Leliveld, A.M., Meijer, R.P., van Melick, H., Merks, B., de Reijke, T.M., de Vries, P., Wymenga, L.F.A., Wijsman, B., Boormans, J.L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5898538/
https://ncbi.nlm.nih.gov/pubmed/29696234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2018.01.007
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi